Patents by Inventor Timothy Connor

Timothy Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20090163424
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 25, 2009
    Applicant: IMMUNEX CORPORATION
    Inventors: Barbara K. FINCK, Larry O'Neal, John D. Pluenneke, Timothy Connor
  • Soluble tumor necrosis factor receptor treatment of medical disorders
    Publication number: 20040220103
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF&agr; by administering a TNF&agr; antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 4, 2004
    Applicant: Immunex Corporation
    Inventors: Barbara K. Finck, Larry O'Neal, John D. Pluenneke, Timothy Connor
  • Inhibition of Fas signaling
    Publication number: 20030170244
    Abstract: The present invention relates to the general field of treating bone marrow failure and cancer. The invention, in part, utilizes inhibitors of Fas antigen (CD95) induced apoptosis to treat bone marrow failure and to improve cancer therapies.
    Type: Application
    Filed: December 12, 2002
    Publication date: September 11, 2003
    Inventors: John D. Pluenneke, Timothy Connor